Bernardetta Nardelli
Human Genome Sciences
Inc., Rockville
Maryland 20850
USA
Name/email consistency: high
- B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases. Nardelli, B., Moore, P.A., Li, Y., Hilbert, D.M. Leuk. Lymphoma (2002)
- Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system. Nardelli, B., Zaritskaya, L., Semenuk, M., Cho, Y.H., LaFleur, D.W., Shah, D., Ullrich, S., Girolomoni, G., Albanesi, C., Moore, P.A. J. Immunol. (2002)
- Synthesis and release of B-lymphocyte stimulator from myeloid cells. Nardelli, B., Belvedere, O., Roschke, V., Moore, P.A., Olsen, H.S., Migone, T.S., Sosnovtseva, S., Carrell, J.A., Feng, P., Giri, J.G., Hilbert, D.M. Blood (2001)
- Dendritic cells and MPIF-1: chemotactic activity and inhibition of endogenous chemokine production by IFN-gamma and CD40 ligation. Nardelli, B., Morahan, D.K., Bong, G.W., Semenuk, M.A., Kreider, B.L., Garotta, G. J. Leukoc. Biol. (1999)